24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer

Patients with prostate cancer who are candidates for stereotactic radiotherapy to the prostate and seminal vesicles will undergo staging exams, which will include prostate specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET-CT). If the PET scan is negative and the uroflowmetry is acceptable, the patients will perform the treatment, after fiducial implantation, simulation CT and magnetic resonance (MR), in a single fraction, delivered with a high-dose-rate (HDR)-like urethral sparing technique. In 70 patients, acute and late toxicity, biochemical control, over

Trial Details

NCT ID
NCT05936736
Phase
NA
Sponsor
IRCCS San Raffaele
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • prostate SBRT
Locations (sample)
  • Milan, MI, Italy|45.46427,9.18951

Key Eligibility Criteria

  • Histological diagnosis of prostate adenocarcinoma, International Society of Urological Pathology (ISUP) grade groups 1-5
  • Patients over 18 years of age
  • Signed informed consent
  • Negative lymph nodes confirmed by imaging (PSMA PET/CT and/or pelvic MRI with and without contrast medium) where recommended by guidelines (interme…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →